Intellia Therapeutics, Inc.
GB ˙ LSE ˙ US45826J1051
14,82 $ ↑1,89 (14,61%)
2026-06-04
AKTIENPREIS
SecurityGB:0JBU / Intellia Therapeutics, Inc.
InstitutionInvesco Ltd.
Latest Disclosed Ownership434,753 shares
Latest Disclosed Value $ 5,573,533
Invesco Ltd. reports 0.34% increase in ownership of 0JBU / Intellia Therapeutics, Inc.

On May 12, 2026 - Invesco Ltd. filed a 13F-HR form disclosing ownership of 434,753 shares of Intellia Therapeutics, Inc. (GB:0JBU) valued at $5,544,883 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 19, 2026 disclosing 433,290 shares of Intellia Therapeutics, Inc.. This represents a change in shares of 0.34% during the quarter. The current value of the position is $6,443,039 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 434,753 1,463 0.34 5,574 43.08 0.0001
2026-02-19 2025-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 433,290 23,870 5.83 3,895 -44.91 0.0006
2025-11-13 2025-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 409,420 157,844 62.74 7,071 199.70 0.0011
2025-08-13 2025-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 251,576 80,401 46.97 2,360 93.84 0.0004
2025-05-12 2025-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 171,175 74,741 77.50 1,217 8.27 0.0002
2025-02-13 2024-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 96,434 3,677 3.96 1,124 -41.03 0.0002
2024-11-12 2024-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 92,757 -3,273 -3.41 1,906 -11.31 0.0004
2024-08-13 2024-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 96,030 -665 -0.69 2,149 -19.21 0.0005
2024-05-14 2024-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 96,695 24,051 33.11 2,660 20.14 0.0006
2024-02-13 2023-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 72,644 6,742 10.23 2,215 6.29 0.0005
2023-11-13 2023-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 65,902 40 0.06 2,084 -22.42 0.0006
2023-08-11 2023-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 65,862 -6,658 -9.18 2,686 -0.63 0.0007
2023-05-12 2023-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 72,520 -345,358 -82.65 2,703 -81.47 0.0008
2023-02-13 2022-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 417,878 13,299 3.29 14,580 -35.61 0.0043
2022-11-14 2022-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 404,579 8,239 2.08 22,641 10.36 0.0073
2022-08-15 2022-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 396,340 7,659 1.97 20,515 -27.37 0.0062
2022-05-16 2022-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 388,681 -88,724 -18.58 28,244 -49.97 0.0072
2022-02-14 2021-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 477,405 -193,791 -28.87 56,449 -37.31 0.0136
2021-11-15 2021-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 671,196 -13,435 -1.96 90,040 -18.77 0.0228
2021-08-17 2021-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 684,631 -546,933 -44.41 110,849 12.15 0.0273
2021-05-17 2021-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 1,231,564 -259,385 -17.40 98,839 21.86 0.0264
2021-02-16 2020-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 1,490,949 1,174,248 370.77 81,107 1,188.23 0.0236
2020-11-16 2020-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 316,701 269,294 568.05 6,296 532.13 0.0021
2020-08-14 2020-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 47,407 27,485 137.96 996 308.20 0.0004
2020-05-15 2020-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 19,922 2,034 11.37 244 -6.87 0.0001
2020-02-14 2019-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 17,888 -1,175 -6.16 262 3.15 0.0001
2019-11-14 2019-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 19,063 -744 -3.76 254 -21.60 0.0001
2019-08-14 2019-06-30 13F/A-1 INTELLIA THERAPEUTICS COM 45826J105 19,807 -675 -3.30 324 -7.43 0.0001
2019-08-14 2019-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 19,807 -675 324
2019-05-15 2019-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 20,482 20,482 350 0.0001
2018-08-14 2018-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 0 -268,551 -100.00 0 -100.00
2018-05-15 2018-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 268,551 268,551 5,664 0.0021
2017-02-14 2016-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 0 -82,974 -100.00 0 -100.00
2016-11-14 2016-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 82,974 -20 -0.02 1,412 -20.27 0.0005
2016-08-15 2016-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 82,994 82,994 1,771 0.0007
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.